We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
-52.98%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$7.7M
AUM Growth
-$9.19M
Cap. Flow
+$57.4K
Cap. Flow %
0.75%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
HOWL icon
Werewolf Therapeutics
HOWL
+$57.4K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRNS
1
Barinthus Biotherapeutics
BRNS
$22.8M
$3.34M 43.39%
642,204
HOWL icon
2
Werewolf Therapeutics
HOWL
$17.2M
$2.59M 33.68%
589,102
+8,200
+1% +$57.4K
TCRX icon
3
TScan Therapeutics
TCRX
$48.6M
$1.76M 22.92%
630,000

Similar funds

DC Funds's Q1 2022 Portfolio in Review

As of Q1 2022, DC Funds held 3 positions worth $7.7M, down 54% from $16.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds added most to Werewolf Therapeutics in Q1 2022, an estimated $57.4K increase.
  • DC Funds's ten largest holdings make up 100% of its $7.7M portfolio in Q1 2022.
  • DC Funds opened 0 new positions and closed 0 in Q1 2022.
  • DC Funds's portfolio value fell 54% quarter-over-quarter to $7.7M.

Based on DC Funds's 13F filing for Q1 2022, filed 13 May 2022.